Back to top

CRVS forms NR7 on July 6

Corvus Pharmaceuticals, Inc. (CRVS) — Nightly Technical Analysis · Jul 6, 2026, 19:55 ET
CRVS finished lower by 0.39% on Monday, July 6th, trading 0.7 times its typical volume. consolidation patterns formed: NR7, suggesting a potential continuation after price stabilization. Key support levels exist at 14.99, 14.82 & 14.46, with resistance at 15.52, 15.88 & 16.05. Slow Stochastic readings suggest the stock is currently overbought.

Current SwingTradeBot Technical Rating of CRVS: A

Don’t miss other key signals CRVS triggered—view them now on SwingTradeBot.com.

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Corvus Pharmaceuticals, Inc. (CRVS)